A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS. 2002 May 24; 16(8):1147-54.